Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2456496rdf:typepubmed:Citationlld:pubmed
pubmed-article:2456496lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2456496lifeskim:mentionsumls-concept:C0439861lld:lifeskim
pubmed-article:2456496lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:2456496lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:2456496pubmed:issue1lld:pubmed
pubmed-article:2456496pubmed:dateCreated1988-9-1lld:pubmed
pubmed-article:2456496pubmed:abstractTextSubstance P has been immunohistochemically localized in the human optic nerves and lateral geniculate nuclei during the prenatal period from 13-14 to 37 weeks of gestation. Substance P-immunoreactive fibres were present in the optic nerves and lateral geniculate nuclei in all these ages thereby providing direct evidence of this undecapeptide being associated with the retinogeniculate pathway. At 16-17 weeks, greater numbers of fibres were observed than in the later ages. It is likely that the reduction in number of optic nerve fibres seen quantitatively during prenatal life may partly be due to the loss of substance P fibres.lld:pubmed
pubmed-article:2456496pubmed:languageenglld:pubmed
pubmed-article:2456496pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2456496pubmed:citationSubsetIMlld:pubmed
pubmed-article:2456496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2456496pubmed:statusMEDLINElld:pubmed
pubmed-article:2456496pubmed:monthJunlld:pubmed
pubmed-article:2456496pubmed:issn0304-3940lld:pubmed
pubmed-article:2456496pubmed:authorpubmed-author:BijlaniVVlld:pubmed
pubmed-article:2456496pubmed:authorpubmed-author:WadhwaSSlld:pubmed
pubmed-article:2456496pubmed:authorpubmed-author:RizviT ATAlld:pubmed
pubmed-article:2456496pubmed:issnTypePrintlld:pubmed
pubmed-article:2456496pubmed:day17lld:pubmed
pubmed-article:2456496pubmed:volume89lld:pubmed
pubmed-article:2456496pubmed:ownerNLMlld:pubmed
pubmed-article:2456496pubmed:authorsCompleteYlld:pubmed
pubmed-article:2456496pubmed:pagination25-30lld:pubmed
pubmed-article:2456496pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2456496pubmed:meshHeadingpubmed-meshheading:2456496-...lld:pubmed
pubmed-article:2456496pubmed:meshHeadingpubmed-meshheading:2456496-...lld:pubmed
pubmed-article:2456496pubmed:meshHeadingpubmed-meshheading:2456496-...lld:pubmed
pubmed-article:2456496pubmed:meshHeadingpubmed-meshheading:2456496-...lld:pubmed
pubmed-article:2456496pubmed:meshHeadingpubmed-meshheading:2456496-...lld:pubmed
pubmed-article:2456496pubmed:meshHeadingpubmed-meshheading:2456496-...lld:pubmed
pubmed-article:2456496pubmed:meshHeadingpubmed-meshheading:2456496-...lld:pubmed
pubmed-article:2456496pubmed:meshHeadingpubmed-meshheading:2456496-...lld:pubmed
pubmed-article:2456496pubmed:meshHeadingpubmed-meshheading:2456496-...lld:pubmed
pubmed-article:2456496pubmed:meshHeadingpubmed-meshheading:2456496-...lld:pubmed
pubmed-article:2456496pubmed:year1988lld:pubmed
pubmed-article:2456496pubmed:articleTitleSubstance P-immunoreactivity in the developing human retinogeniculate pathway.lld:pubmed
pubmed-article:2456496pubmed:affiliationDepartment of Anatomy, All-India Institute of Medical Sciences, New Delhi.lld:pubmed
pubmed-article:2456496pubmed:publicationTypeJournal Articlelld:pubmed